Skip to main content

Advertisement

SpringerLink
Log in

Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood 2007; 109: 3489–3495.

    Article  CAS  Google Scholar 

  2. Chang H, Sloan S, Li D, Zhuang L, Yi QL, Chen CI et al. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. Br J Haematol 2004; 125: 64–68.

    Article  Google Scholar 

  3. Trudel S, Li ZH, Wei E, Wiesmann M, Chang H, Chen C et al. CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. Blood 2005; 105 (Suppl 7): 2941–2948.

    Article  CAS  Google Scholar 

  4. Chang H, Stewart AK, Qi XY, Li ZH, Yi QL, Trudel S . Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma. Blood 2005; 106: 353–355.

    Article  CAS  Google Scholar 

  5. Keats JJ, Maxwell CA, Taylor BJ, Hendzel MJ, Chesi M, Bergsagel PL et al. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients. Blood 2005; 105: 4060–4069.

    Article  CAS  Google Scholar 

  6. Fonseca R, Oken MM, Greipp PR . The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance. Blood 2001; 98: 1271–1272.

    Article  CAS  Google Scholar 

  7. Zhan F, Huang Y, Colla S, Stewart JP, Hanamura I, Gupta S et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020–2028.

    Article  CAS  Google Scholar 

  8. Chandesris MO, Soulier J, Labaume S, Crinquette A, Repellini L, Chemin K et al. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma. Br J Haematol 2007; 136: 609–614.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Multiple Myeloma Research Consortium and Multiple Myeloma Research Foundation.

Author information

Authors and Affiliations

  1. Division of Hematology – Oncology, Mayo Clinic College of Medicine, Scottsdale, AZ, USA

    A K Stewart, J Keats, S Van Wier, G Ahmann, T Price-Troska, P L Bergsagel, M Chesi & R Fonseca

  2. Department of Medical Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada

    H Chang, S Trudel, D Reece & Z Li

  3. Department of Hematology – Oncology, Dana Farber Cancer Institute, Boston, MA, USA

    K C Anderson & P Richardson

  4. Division of Hematology–Oncology, Moffit Cancer Center, Tampa, FL, USA

    M Alsina

  5. Multiple Myeloma Research Consortium, New Caanan, CT, USA

    S Young, A Sable-Hunt & K Giusti

Authors
  1. A K Stewart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Trudel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K C Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Alsina
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D Reece
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Young
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A Sable-Hunt
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Z Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. J Keats
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S Van Wier
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. G Ahmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. T Price-Troska
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. K Giusti
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. P L Bergsagel
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. M Chesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. R Fonseca
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A K Stewart.

Additional information

Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stewart, A., Chang, H., Trudel, S. et al. Diagnostic evaluation of t(4;14) in multiple myeloma and evidence for clonal evolution. Leukemia 21, 2358–2359 (2007). https://doi.org/10.1038/sj.leu.2404800

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2404800

  • Springer Nature Limited

This article is cited by

Search

Navigation